Dermata Therapeutics
DRMA
9 hedge funds and large institutions have $101K invested in Dermata Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 4 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
10% less funds holding
Funds holding: 10 → 9 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
28% less capital invested
Capital invested by funds: $140K → $101K (-$39.4K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$46.8K |
| 2 |
Jane Street
New York
|
+$15.6K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$7.8K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.24K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.56K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$52K |
| 2 |
Citigroup
New York
|
-$32K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$7K |
| 4 |
AC
Armistice Capital
New York
|
-$414 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $37K | +$46.8K | +30 | New |
|
2
Geode Capital Management
Boston,
Massachusetts
| $13K | – | – | – |
|
|
3
Wells Fargo
San Francisco,
California
| $13K | +$7.8K | +5 | +100% |
|
|
4
Jane Street
New York
| $12K | +$15.6K | +10 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $8K | +$1.56K | +1 | +20% |
|
|
SCA
6
Sage Capital Advisors
Sioux Falls,
South Dakota
| $6K | – | – | – |
|
7
Tudor Investment Corp
Stamford,
Connecticut
| $5K | – | – | – |
|
|
8
Fidelity Investments
Boston,
Massachusetts
| $5K | +$6.24K | +4 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $2K | – | – | – |
|
|
AC
10
Armistice Capital
New York
| – | -$414 | -265 | Closed |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$52K | -33 | Closed |
|
|
12
Citigroup
New York
| – | -$32K | -20 | Closed |
|
|
13
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$7K | -5 | Closed |
|
DRMA Hedge Fund Activity: Q3 2022 in Review
9 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Dermata Therapeutics (DRMA) for Q3 2022, worth a combined $101K — down 28% from $140K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of DRMA and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $46.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $52K sold.
- 9 institutional investors held Dermata Therapeutics (DRMA) as of Q3 2022, down from 10 in Q2 2022.
- Funds reported $101K of Dermata Therapeutics stock for Q3 2022, down 28% quarter-over-quarter.
- 3 funds opened new Dermata Therapeutics positions in Q3 2022 and 4 closed out, a net change of -1 holder.
- The largest Dermata Therapeutics buyer in Q3 2022 was Virtu Financial, an estimated $46.8K added.
- The largest Dermata Therapeutics seller in Q3 2022 was Citadel Advisors, an estimated $52K sold.
Based on aggregated 13F filings for Q3 2022.